Zoetis Inc. (ZTS)
Health Care / Pharmaceuticals
S&P 500$74.80
Below average on several measures. Research carefully.
Weak
Score based on 5 of 5 models — high confidence
Is Zoetis Inc. a Good Investment in 2026?
Zoetis Inc. (ZTS) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Zoetis Inc. as Strong (7/9). The Graham model is the least favorable, rating it Neutral. Zoetis Inc. ranks #763 out of 1121 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 12x earnings — near sector median of 27x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Strong
Business quality & competitive moat
Graham
Neutral
Significantly above fair value
Lynch
Attractive
PEG 0.6 · Fast Grower
Greenblatt
Strong
Top 25% (rank 13%)
Frequently Asked Questions
Is Zoetis Inc. (ZTS) a good investment?
What is Zoetis Inc.'s Piotroski F-Score?
Is ZTS overvalued or undervalued?
How does ZTS compare to other Health Care stocks?
What do investment models say about ZTS?
Similar Stocks
Compare ZTS with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer